Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
While 19 million people have type 2 diabetes mellitus, 54 million individuals show impaired fasting glucose as adults, which may represent a prediabetic state. This study examined the prediction of normal fasting plasma glucose (FPG) levels for the development of type 2 diabetes during a 21-year period beginning in childhood. The results show a significantly increased risk (>2-fold) for developing adult prediabetes and type 2 diabetes in children with an FPG of 86 to 99 mg/dL (to convert to millimoles per liter, multiply by 0.0555) compared with those with an FPG of less than 86 mg/dL, even after controlling for other traditional cardiometabolic risk factors. This observation suggests that elevated FPG within the currently accepted normal range in childhood may portend a diabetic status (prediabetes and diabetes) in young adulthood.
Prevalence of adult diabetes status by quartiles of childhood fasting plasma glucose levels within the normoglycemic range. Levels of fasting plasma glucose according to the quartiles were less than 80 mg/dL for quartile 1; 80 to 85 mg/dL, quartile 2; 86 to 90 mg/dL, quartile 3; and 91 to 99 mg/dL, quartile 4.
See Article
While metformin is commonly used as a primary or adjunctive treatment in obese, nondiabetic adolescents, there are limited short-term data to support this therapy. This 48-week randomized, double-blind, placebo-controlled trial of extended-release (XR) metformin therapy in nondiabetic obese adolescents was conducted in 5 clinical sites in the United States. Metformin XR had a small, but statistically significant, impact on body mass index during the initial 52 weeks of the study; this difference disappeared by 24 weeks after cessation of the drug. There were no significant effects on central adiposity, insulin indices, or lipids during metformin therapy. Longer-term studies will be needed to define the effects of metformin treatment on obesity-related disease risk in this population.
Adjusted change in body mass index (BMI [calculated as the mean weight in kilograms divided by the mean height in meters squared]) from baseline. Data are plotted as the mean and 1 SE. The vertical line separates the study drug treatment and post–study drug treatment monitoring periods.
Despite the widespread implementation of abstinence interventions for prevention of sexual risk behaviors in adolescents and the controversy regarding their appropriateness, few randomized controlled trials have tested their efficacy. In this study, African American sixth- and seventh-grade students were randomly assigned to an 8-hour abstinence-only intervention, an 8-hour safer sex–only intervention, an 8- or 12-hour combined abstinence and safer-sex intervention, or an 8-hour health-promotion control group. The probability of ever having sexual intercourse by the 24-month follow-up was 33.5% in the abstinence-only intervention and 48.5% in the health-promotion control group; the safer-sex and comprehensive interventions did not differ from the control group in sexual initiation. None of the interventions had significant effects on consistent condom use or unprotected intercourse. Selective use of theory-based abstinence-only interventions might contribute to the overall goal of curbing the spread of sexually transmitted infections in both the United States and other countries.
A considerable body of research has established the efficacy of stimulant medication for reducing attention-deficit/hyperactivity disorder (ADHD) symptomatology in patients with ADHD when administered according to detailed medication protocols. This study reports on the outcomes of 785 children with ADHD treated in 47 practices (158 physicians) participating in the ADHD Collaborative quality-improvement project. Children who received ADHD care in community-based primary care practices participating in the ADHD Collaborative experienced significant reductions in ADHD symptoms over time. Symptom improvement occurred mainly within the first 3 months of treatment and remained relatively stable thereafter. These results suggest that community-based physicians can achieve gains in ADHD symptom improvement comparable with carefully controlled, university-based clinical trials.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Pediatrics and Adolescent Medicine editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.